Related Experiment Video
Updated: Jun 7, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Oncolytic viruses in cutaneous oncology: Mechanisms, clinical applications, and future directions
Goranit Sakunchotpanit1, Mihir K Patil2, Ruhi Kanwar3
1Department of Dermatology, Brigham and Women's Hospital, Boston, MA, United States; Tufts University School of Medicine, Boston, MA, United States.
Abstract:
Oncolytic viruses (OVs) are a rapidly expanding class of anti-neoplastic management options that utilize the innate infectivity of either native or modified viruses to preferentially lyse malignant cells while sparing healthy ones. Some OVs naturally target antigens within a tumor micro-environment, while others are re-oriented to identify specific targets via deletion of or addition to their existing genetic makeup. This chapter focuses on OVs in cutaneous oncology, providing an overview of their molecular mechanisms, clinical applications across a variety of disease states, and future directions for the field.
Insights
Oncolytic viruses (OVs) are innovative cancer treatments that destroy cancer cells. This chapter explores OVs in skin cancer, detailing their mechanisms, uses, and future potential.
Area of Science:
- Oncolytic virotherapy
- Cutaneous oncology
- Molecular oncology
Background:
- Oncolytic viruses (OVs) are emerging anti-cancer agents.
- OVs selectively infect and lyse malignant cells, sparing healthy tissues.
- Viruses can be naturally tumor-targeting or genetically modified for specific antigen recognition.
Purpose of the Study:
- To provide an overview of oncolytic viruses in cutaneous oncology.
- To discuss the molecular mechanisms of OV action.
- To review clinical applications and future directions for OVs in skin cancer.
Main Methods:
- Review of molecular mechanisms of OV targeting and lysis.
- Analysis of clinical data for OVs in various skin cancer types.
- Exploration of future research and therapeutic strategies for OVs.
Main Results:
- OVs demonstrate selective lysis of cancer cells.
- Genetically engineered OVs enhance tumor targeting capabilities.
- Clinical applications show promise across diverse cutaneous malignancies.
Conclusions:
- Oncolytic viruses represent a promising therapeutic strategy in cutaneous oncology.
- Understanding OV molecular mechanisms is key to optimizing treatment efficacy.
- Continued research and clinical trials are essential for advancing OV-based therapies in skin cancer.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
